Non-endocrine applications of somatostatin and octreotide acetate: facts and flights of fancy

Krulich, 1968, Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro, Endocrinology, 83, 783, 10.1210/endo-83-4-783 Brazeau, 1973, Hypothalamic peptide that inhibits immunoreactive pituitary growth hormone, Science, 179, 77, 10.1126/science.179.4068.77 Vale, 1974, Effects of somatostatin on the secretion of thyrotropin and prolactin, Endocrinology, 95, 968, 10.1210/endo-95-4-968 Hellman, 1969, Inhibition of the in vitro secretion of insulin by an extract of pancreatic α1 cells, Endocrinology, 84, 1484, 10.1210/endo-84-6-1484 Bloom, 1974, Inhibition of gastrin and gastric acid secretion, Lancet, 2, 1106, 10.1016/S0140-6736(74)90869-1 Pederson, 1975, The effect of somatostatin on release and insulinotropic action of gastric inhibitory polypeptide, Can J Physiol Pharmacol, 53, 1200, 10.1139/y75-168 Petel, 1986, Somatostatin: some aspects of its physiology Marco, 1977, Inhibitory effect of somatostatin on human pancreatic polypeptide secretion, Life Sci, 21, 789, 10.1016/0024-3205(77)90406-4 Schlegel, 1977, Inhibition of cholecystokinin-pancreozymin release by somatostatin, Lancet, 2, 166, 10.1016/S0140-6736(77)90182-9 Bloom, 1975, Proceedings: Effect of somatostatin on motilin and gastric emptying, Gut, 16, 834 Boden, 1975, Somatostatin suppresses secretin and pancreatic exocrine secretion, Science, 190, 163, 10.1126/science.1166308 Osei, 1985, Effects of somatostatin and gastroenteropancreatic hormones in a malignant insulinoma patient, Clin Res, 33, 312A Mozell, 1990, Adult onset nesidioblastosis: response of glucose, insulin and secondary peptides to therapy with sandostatin, Am J Gastroenterol, 85, 181 Mozell, 1990, Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndrome, Surg Gynecol Obstet, 170, 474 Boden, 1986, Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995, N Engl J Med, 314, 1686, 10.1056/NEJM198606263142606 Brabant, 1986, Treatment of carcinoid syndrome and VIPoma with a long-acting somatostatin analogue (SMS 201-995), Scand J Gastroenterol, 21, 177, 10.3109/00365528609087448 Tolis, 1988, Long-term management of acromegaly with sandostatin, Horm Res, 29, 112, 10.1159/000180983 Lamberts, 1986, The sensitivity of growth hormone and prolactin secretion to the somatostatin analog SMS 201-995 in patients with prolactinomas and acromegaly, Clin Endocrinol, 25, 201, 10.1111/j.1365-2265.1986.tb01683.x Beck-Peccoz, 1988, Treatment of inappropriate secretion of thyrotropin with somatostatin analog SMS 201-995, Horm Res, 29, 121, 10.1159/000180986 Navascues, 1988, Effect of a long-acting somatostatin derivative SMS 201-995 (Sandostatin) on glucose homeostasis in type I diabetes mellitus, Horm Res, 29, 92, 10.1159/000180977 Gerich, 1975, Prevention of human diabetic ketoacidosis by somatostatin: evidence for an essential role of glucagon, N Engl J Med, 292, 985, 10.1056/NEJM197505082921901 Arnold, 1980, Somatostatin and the gastrointestinal tract, Clin Gastroenterol, 9, 733, 10.1016/S0300-5089(21)00481-8 Levin, 1983, Effects of somatostatin on gallbladder emptying in man, Clin Res, 31, 285A Bolaffi, 1980, Somatostatin: occurrence in urinary bladder epithelium and renal tubules of the toad, buto marinus, Science, 210, 644, 10.1126/science.6107992 Yamada, 1977, Immunohistochemical demonstration of somatostatin-containing cells in the human, dog and rat thyroids, Tohoku J Exp Med, 122, 87, 10.1620/tjem.122.87 Bennett-Clark, 1988, Distribution of somatostatin in the rat brain: telencephalon and diencephalon, Brain Res, 188, 473, 10.1016/0006-8993(80)90046-3 Jenkins, 1985, Effects of a somatostatin analogue SMS 201-995 in hepatic hemodynamics in the pig and on intravariceal pressure in man, Br J Surg, 72, 1009, 10.1002/bjs.1800721225 Kravetz, 1988, Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats, Am J Physiol, 254, G322 Jenkins, 1985, The effects of a somatostatin analogue SMS 201-995 on hepatic hemodynamics in the cirrhotic rat, Br J Surg, 72, 864, 10.1002/bjs.1800721105 Cambria, 1987, Somatostatin and analogs lack splanchnic vasoconstrictive effects in anesthetized pigs, J Surg Res, 43, 452, 10.1016/0022-4804(87)90104-1 Sonnenberg, 1981, Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects, Gastroenterology, 80, 526, 10.1016/0016-5085(81)90015-9 Eriksson, 1987, Hemodynamic effects of a longacting somatostatin analogue in patients with liver cirrhosis, Scand J Gastroenterol, 22, 919, 10.3109/00365528708991936 Bosch, 1981, Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin, Gastroenterology, 80, 518, 10.1016/0016-5085(81)90014-7 Samnegard, 1980, Effect of somatostatin on regional splanchnic blood flows in man, S500, 71 Price, 1985, Effect of exogenous somatostatin infusion on gastrointestinal blodd flow and hormones in the conscious dog, Gastroenterology, 88, 80, 10.1016/S0016-5085(85)80136-0 Burroughs, 1985, Effect of a long-acting analogue of somatostatin (SMS 201-995) on hepatic venous pressures and axygous blood flow in cirrhotics, Gut, 26, A562 Baxter, 1987, Samatostatin 201-995 and variceal hemorrhage, Acta Endocrinol, 116, 37, 10.1530/acta.0.115S037 Kleber, 1988, Somatostatin does not reduce esophageal variceal pressure in liver cirrhotics, Gut, 29, 153, 10.1136/gut.29.2.153 Panconesi, 1987, Somatostatin: peripheral vasoconstrictive activity and interaction with monoamines in man, Regul Pept, 18, 267, 10.1016/0167-0115(87)90184-4 Raptis, 1979, Somatostatin is not helpful in bleeding esophageal varices, N Engl J Med, 300, 736, 10.1056/NEJM197903293001317 Tyden, 1978, Treatment of bleeding esophageal varices with somatostatin, N Engl J Med, 299, 1466, 10.1056/NEJM197812282992614 Konturek, 1985, Effect of somatostatin-14 and somatostatin-28 on plasma hormonal and gastric secretory responses to cephalic and gastrointestinal stimuli in man, Scand J Gastroenterol, 20, 31, 10.3109/00365528509089629 Uvnas-Wallensten, 1981, Acta Physiol Scand, 111, 397, 10.1111/j.1748-1716.1981.tb06755.x Grossman, 1979, Neural and hormonal regulation of gastrointestinal function: an overview, Annu Rev Physiol, 41, 27, 10.1146/annurev.ph.41.030179.000331 Larsson, 1979, Somatostatin cell processes as pathways for paracrine secretion, Science, 205, 1393, 10.1126/science.382360 Torres, 1986, Antral gastrin-producing G-cells and somatostatin-producing D-cells in peptic ulcer, Virchows Arch, 410, 165, 10.1007/BF00710821 Park, 1987, Mechanisms for direct inhibition of canine gastric parietal cells by somatostatin, J Biol Chem, 29, 14190, 10.1016/S0021-9258(18)47922-7 Zdon, 1987, Somatostatin analogue inhibition of isolated parietal cell secretion, Surgery, 102, 967 Michelangeli, 1988, Somatostatin inhibition of secretagogue and forskolin-stimulated gastric acid secretion, Am J Physiol, 254, G531 Seefried, 1988, Gastric secretion and gastrin under progressive doses of somatostatin-14 and somatostatin-28 administered intraperitoneally to the rat, Regul Pept, 9, 249 Longong, 1987, Pharmacologic effect of secretin and somatostatin on gastric and renal function in man, Scand J Gastroenterol, 139, 25, 10.3109/00365528709089771 Gomez-Pan, 1975, Direct inhibition of gastric acid and pepsin secretion by growth hormone release-inhibiting hormone in cats, Lancet, 1, 888, 10.1016/S0140-6736(75)91686-4 Hirschowitz, 1987, Somatostatin effects on gastric electrolytes and pepsin in dogs with various secretory stimuli, J Pharmacol Exp Ther, 243, 501 Sandvik, 1988, The effect of somatostatin on baseline and stimulated acid secretion and vascular histamine release from the totally isolated vascularly perfused rat stomach, Regul Pept, 20, 233, 10.1016/0167-0115(88)90079-1 Seal, 1988, Immunoneutralization of somatostatin and neurotensin: effect of gastric acid secretion, Am J Physiol, 255, 640 Seal, 1982, Somatostatin-14 and −28: clearance and potency on gastric function in dogs, Am J Physiol, 243, G97 Chiba, 1980, Effects of glucagon, secretin and vasoactive intestinal polypeptide on gastric somatostatin and gastrin release from isolated perfused rat stomach, Gastroenterology, 79, 67, 10.1016/0016-5085(80)90076-1 Martindale, 1982, Differential regulation of gastrin and somatostatin secretion from isolated perfused rat stomachs, Gastroenterology, 83, 240, 10.1016/0016-5085(82)90181-0 Wolfe, 1984, Effects of carbachol on gastrin and somatostatin release in rat antral tissue culture, Gastroenterology, 87, 86, 10.1016/0016-5085(84)90129-X Harty, 1981, Somatostatin inhibition of basal and carbachol-stimulated gastrin release in rat antral organ culture, Gastroenterology, 81, 707, 10.1016/0016-5085(81)90495-9 Hayes, 1975, Inhibition of gastrin release by somatostatin in vitro, Endocrinology, 96, 1374, 10.1210/endo-96-6-1374 Nylander, 1984, Dual inhibitory actions of somatostatin on isolated gastric glands, Acta Physiol Scand, 125, 111, 10.1111/j.1748-1716.1985.tb07697.x Hong, 1988, Somatostatin modulation of neurally mediated pepsinogen secretion from frog esophageal mucosa, Biochim Biophys Acta, 968, 401, 10.1016/0167-4889(88)90033-X Johansson, 1982, Stimulation of gastric mucous output by somatostatin in man, Eur J Clin Invest, 12, 37, 10.1111/j.1365-2362.1982.tb00937.x Lunde, 1987, Effect of somatostatin on human gastric blood flow evaluated by endoscopic laser Doppler flowmetry, Scand J Gastroenterol, 22, 842, 10.3109/00365528708991924 Somerville, 1985, Somatostatin in the treatment of haematemesis and melaena, Lancet, 1, 130, 10.1016/S0140-6736(85)91903-8 Magnusson, 1985, Randomized double-blind trial of somatostatin in the treatment of massive upper gastrointestinal hemorrhage, Gut, 26, 221, 10.1136/gut.26.3.221 Kayasseh, 1980, Somatostatin and cimetidine in peptic ulcer haemorrhage: a randomised controlled trial, Lancet, 1, 844, 10.1016/S0140-6736(80)91352-5 Limberg, 1980, Somatostatin for cimetidine-resistant gastroduodenal hemorrhage, Lancet, 2, 916, 10.1016/S0140-6736(80)92073-5 Torres, 1988, Somatostatin in the treatment of severe upper gastrointestinal bleeding: a multicentre controlled trial, Br J Surg, 73, 786, 10.1002/bjs.1800731009 Corraggio, 1984, Somatostatin and ranitidine in the control of iatrogenic hemorrhage of the upper gastrointestinal tract, Br Med J, 289, 224, 10.1136/bmj.289.6439.224 Christiansen, 1986, The role of SMS and a long-acting analogue SMS 201-995 in acute bleeding due to peptic ulceration, Scand J Gastroenterol, 119, 109, 10.3109/00365528609087438 Priebe, 1980, Antacid versus cimetidine in preventing acute gastrointestinal bleeding: a randomized trial in 75 critically ill patients, N Engl J Med, 302, 426, 10.1056/NEJM198002213020802 Green, 1978, Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor to prolonged gastroduodenal mucosal hemorrhage, Gastroenterology, 74, 38, 10.1016/0016-5085(78)90352-9 Konturek, 1988, Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats, Gastroenterology, 94, 1300, 10.1016/0016-5085(88)90667-1 Misumi, 1986, Effect of SMS 201-995, a somatostatin analog, on the exocrine pancreatic secretion in dogs, Dig Dis Sci, 31, 1142 Ellison, 1985, The effect of long-acting somatostatin anolog (SMS 201-995) on basal pancreatic exocrine function in man, Gastroenterology, 88, 1373 Esteve, 1984, Binding of somatostatin to pancreatic acinar cells, Am J Physiol, 247, G62 Osnes, 1979, The unstimulated pancreatic secretion obtained by endoscopic cannulation and the plasma secretin levels in man, Scand J Gastroenterol, 14, 503 Magee, 1984, The role of motilin in periodic interdigestive pancreatic secretion in dogs, J Physiol, 355, 441, 10.1113/jphysiol.1984.sp015429 Chey, 1984, Potentiating effect of secretion on cholecystokinin-stimulated pancreatic secretion in dogs, Am J Physiol, 246, G248 Misumi, 1988, Effects of SMS 201-995, a somatostatin analog, on the exocrine pancreatic secretion and gut hormone release in dogs, Surgery, 103, 450 Raptis, 1978, Effects of somatostatin on the exocrine pancreas and the release of duodenal hormones, Metabolism, 27, 1321, 10.1016/0026-0495(78)90066-5 Shiratori, 1986, The role of exogenous pancreatic polypeptide on the pancreatic exocrine secretion in dogs, Gastroenterology, 90, 1632 Gullo, 1987, Effect of somatostatin-14 on pure human pancreatic secretion, Dig Dis Sci, 32, 1065, 10.1007/BF01300189 Stöckman, 1986, Influence of SMS 201-995, a long-acting somatostatin analogue, on exocrine pancreatic secretion in the rat, Dig Dis Sci, 31, 1151 Escourrou, 1987, Inhibition of pancreatic exocrine secretion in man by somatostatin: comparison of three molecular forms: S-28, S-14, S-8, Gastroenterology, 92, 1385 Welton, 1988, The long-acting somatostatin analogue SMS 201-995 is a potent inhibitor of canine pancreatic exocrine function, Gastroenterology, 94, A493 Kohler, 1985, Effects of graded doses of SMS 201-995 on exocrine and endocrine pancreatic function, Digestion, 32, 196 Lembcke, 1987, Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men, Digestion, 36, 108, 10.1159/000199408 Hanssen, 1977, Inhibition of secretion and pancreatic bicarbonate secretion by somatostatin infusion in man, Scand J Gastroenterol, 12, 391, 10.3109/00365527709181678 Konturek, 1976, Effect of growth hormone-release inhibiting hormone on hormone stimulated exocrine pancreatic secretion, J Clin Invest, 58, 1, 10.1172/JCI108438 Meyer, 1983, Pancreatic physiology Fahrenkrug, 1979, Vasoactive intestinal peptide in vagally mediated pancreatic secretion of fluid and bicarbonate, Am J Physiol, 237, E535 Goodgame, 1986, Pancreatic secretion in man: effects of drugs, somatostatin, porcine pancreatic supplements, or intraduodenal infusion of pure pancreatic juice, Gastroenterology, 90, 1433 Ronconi, 1983, Effect of somatostatin on exocrine pancreas evaluated on a total external pancreatic fistula of neoplastic origin, Am J Gastroenterol, 79, 425 Prinz, 1988, Treatment of pancreatic cutaneous fistula with a somatostatin analogue, Am J Surg, 155, 36, 10.1016/S0002-9610(88)80255-1 Woltering, 1990, Treatment of nonendocrine gastrointestinal disorders with octreotide acetate, Metabolism, 39, 176, 10.1016/0026-0495(90)90240-D Williams, 1989, Effect of octreotide acetate on pancreatic exocrine function, Am J Surg, 157, 459, 10.1016/0002-9610(89)90634-X Pederzoli, 1986, Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with somatostatin, glucagon or calcitonin, Surg Gynecol Obstet, 163, 428 Ellison, 1986, Successful treatment of pancreatic ascites with somatostatin analog (SMS 201-995), Gastroenterology, 90, 1405 Sahel, 1982, Clinicopathological conditions associated with pancreas divisum, Digestion, 23, 1, 10.1159/000198689 Acosta, 1980, Etiology and pathogenesis of acute biliary pancreatitis, Surgery, 88, 118 Guy, 1983, Protein content of precipitates present in pancreatic juice of alcoholic subjects and patients with chronic calcifying pancreatitis, Gastroenterology, 84, 102, 10.1016/S0016-5085(83)80172-3 Harvey, 1988, Possible mechanisms of acute pancreatitis induced by ethanol, Am J Surg, 155, 49, 10.1016/S0002-9610(88)80257-5 Surlesi, 1981, Action of gastrointestinal hormones on the myoelectric activity of the sphincter of Oddi in living rabbit, Regul Pept, 2, 113, 10.1016/0167-0115(81)90005-7 Bauer, 1987, Non-adrenergic, non-cholinergic (NANC) inhibitory innervation of the canine and opossum sphincter of Oddi, Gastroenterology, 92, 1311 Allan, 1973, Intraductal activation of pancreatic zymogens behind a carcinoma of the pancreas, Gastroenterology, 65, 412, 10.1016/S0016-5085(19)33072-0 Sahel, 1979, Modifications of pure human pancreatic juice induced by chronic alcohol consumption, Gastroenterology, 76, 1233 Demol, 1980, Chronic ethanol consumption and exocrine pancreatic response to ethanol and acetaldehyde in the rat, Digestion, 20, 85, 10.1159/000198423 Planche, 1982, Effects of intravenous alcohol on pancreatic and biliary secretion in man, Dig Dis Sci, 27, 449, 10.1007/BF01295655 Ohlsson, 1973, Experimental pancreatitis in the dog: demonstration of trypsin in ascitic fluid, lymph and plasma, Scand J Gastroenterol, 8, 129, 10.1080/00365521.1973.12096681 Farmer, 1984, Effects of bile salts on permeability and morphology of the main pancreatic duct in cats, Dig Dis Sci, 29, 740, 10.1007/BF01312948 Arnesjo, 1971, The formation of lysolecithin in the rat pancreas after experimentally induced bile salt pancreatitis, Acta Chir Scand, 137, 351 Reber, 1979, The pancreatic duct mucosal barrier, Am J Surg, 137, 128, 10.1016/0002-9610(79)90023-0 Gregg, 1977, Detection of bacterial infection of the pancreatic duct in patients with pancreatitis and pancreatic carcinoma during endoscopic cannulation of the pancreatic duct, Gastroenterology, 73, 1005, 10.1016/S0016-5085(19)31848-7 Wedgewood, 1986, A model of hemorrhagic pancreatitis in cats—role of 16, 16-dimethyl prostaglandin in E2, Gastroenterology, 90, 32, 10.1016/0016-5085(86)90071-5 Ziegler, 1985, Modified somatostatins as inhibitors of a multispecific transport system for bile acids and phallotoxins in isolated hepatocytes, Biochim Biophys Acta, 845, 86, 10.1016/0167-4889(85)90058-8 Rao, 1984, Cytoprotection by novel synthetic analogues of somatostatin, Acta Endocrinol, 105, 96, 10.1530/acta.0.107S096 Steer, 1988, Pathogenesis of acute pancreatitis, Annu Rev Med, 39, 95, 10.1146/annurev.me.39.020188.000523 Darle, 1970, Ultrastructure of the rat exocrine pancreas after long-term intake of ethanol, Gastroenterology, 58, 62, 10.1016/S0016-5085(70)80094-4 Altimari, 1986, Comparison of a long-acting somatostatin analogue and trasylol for treatment of experimental pancreatitis, Can J Physiol Pharmacol, 64, 72 Niderau, 1986, Beneficial effects of cholecystokinin receptor blockage and inhibition of proteolytic enzymes activated in experimental acute hemorrhagic pancreatitis in mice: evidence for cholecystokinin as a major factor in the development of acute pancreatitis, J Clin Invest, 78, 1056, 10.1172/JCI112661 Schwedes, 1979, Effect of somatostatin on bile-induced acute hemorrhagic pancreatitis in the dog, Horm Metab Res, 11, 655, 10.1055/s-0028-1092793 Baxter, 1985, Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat, Br J Surg, 72, 382, 10.1002/bjs.1800720516 Lasson, 1984, Protease inhibitors in acute human pancreatitis: correlation between biochemical changes and clinical course, Scand J Gastroenterol, 19, 779, 10.1080/00365521.1984.12005808 Lasson, 1983, Influence of plasma proteinase inhibitors and aprotinin on trypsin-induced bradykinin release in vitro in man, Hoppe Seylers Z Physiol Chem, 364, 1315, 10.1515/bchm2.1983.364.2.1315 Lasson, 1982, An in vitro study of the influence of plasma protease inhibitors and aprotinin on trypsin-induced C3 cleavage in human serum, Biochim Biophys Acta, 709, 227, 10.1016/0167-4838(82)90465-4 Pawlikowski, 1987, Somatostatin and its analog enhance the formation of leukocyte migration inhibiting factor: further evidence for immunomodulatory action of somatostatin, Peptides, 8, 951, 10.1016/0196-9781(87)90087-8 Ellenbogen, 1988, The effects of somatostatin 201-995 on reticuloendothelial system activity and pulmonary function in rats with acute pancreatitis, Br J Surg, 75, 606 Baxter, 1985, Effects of a somatostatin analogue (somatostatin 201-995) on liver and splenic reticuloendothelial function in the rat, Br J Surg, 72, 1005, 10.1002/bjs.1800721224 Limburg, 1980, Treatment of acute pancreatitis with somatostatin, N Engl J Med, 303, 284, 10.1056/NEJM198007313030516 Bordas, 1988, Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy, Horm Res, 29, 106, 10.1159/000180981 Mix, 1922, Dumping stomach after gastrojejunostomy, Surg Clin North Am, 2, 617 Lawaetz, 1982, Gastric emptying after peptic ulcer surgery: some pathophysiologic mechanisms of the dumping syndrome, Scand J Gastroenterol, 17, 1065 Bergstrom, 1960, The efferent loop dumping syndrome and its relationship to intestinal absorption as studied by an intubation technique, Acta Chir Scand, S265, 6 Christoffersson, 1962, Intestinal motility during provocative dumping reaction, Acta Chir Scand, 123, 405 Sigstad, 1970, A clinical diagnostic index in the diagnosis of the dumping syndrome: changes in the plasma volume and blood glucose after a test meal, Acta Med Scand, 188, 479, 10.1111/j.0954-6820.1970.tb08072.x Lequesne, 1960, The dumping syndrome. I. Factors responsible for the symptoms, Br Med J, 1, 141, 10.1136/bmj.1.5167.141 Ruckebusch, 1976, The effect of feeding on the motility of the stomach and small intestine in the pig, Br J Nutr, 35, 397, 10.1079/BJN19760045 Itoh, 1976, Motilin-induced mechanical activity in the canine gastrointestinal tract, Scan J Gastroenterol, 11, 93 Wingate, 1976, Motilin-induced electrical activity in the canine gastrointestinal tract, Scand J Gastroenterol, 11, 111 Mintzregs, 1976, Release of motilin in man, Scand J Gastroenterol, 11, 53 Rees, 1982, Human interdigestive and postprandial gastrointestinal motor and gastrointestinal hormone patterns, Dig Dis Sci, 27, 321, 10.1007/BF01296751 Eeckhout, 1984, Different meals produce different digestive motility patterns, Dig Dis Sci, 29, 219, 10.1007/BF01296255 Richards, 1990, Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome, J Surg Res, 49, 483, 10.1016/0022-4804(90)90172-X Thor, 1978, Effect of somatostatin on myoelectrical activity of small bowel, Am J Phys, 235, E249 Thor, 1982, (Gln4)-Neurotensin changes the motility pattern of the duodenum from a fasting type to a fed type, Gastroenterology, 83, 569, 10.1016/S0016-5085(82)80191-1 Peskin, 1962, The role of serotonin in the “dumping syndrome”, Arch Surg, 85, 701, 10.1001/archsurg.1962.01310050003001 Lawaetz, 1983, Gut hormone profile and gastric emptying in the dumping syndrome: a hypothesis concerning the pathogenesis, Scand J Gastroenterol, 18, 73, 10.3109/00365528309181562 Blackburn, 1983, Plasma neurotensin and gastric emptying in the dumping syndrome, Life Sci, 32, 833, 10.1016/0024-3205(83)90219-9 Sagor, 1981, Release of vasoactive intestinal polypeptide in the dumping syndrome, Br Med J, 282, 507, 10.1136/bmj.282.6263.507 Geer, 1990, Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome, Ann Surg, 212, 678, 10.1097/00000658-199012000-00005 Zeitlin, 1966, 5-hydroxyindoles and kinins in the carcinoid and dumping syndromes, Lancet, 2, 986, 10.1016/S0140-6736(66)92924-2 Domschke, 1978, Vasoactive intestinal polypeptide in man: pharmacokinetics, metabolic and circulatory effects, Gut, 19, 1049, 10.1136/gut.19.11.1049 Bloom, 1978, Effect of motilin on gastric emptying of solid meals in man, Gastroenterology, 74, 1010 Polak, 1977, Specific localization of neurotensin to the neurotensin cell in human intestine by radioimmunoassay and immunocytochemistry, Nature, 270, 183, 10.1038/270183a0 Blackburn, 1983, A radioimmunoassay for neurotensin in human plasma, J Endocrinol, 83, 175, 10.1677/joe.0.0830175 Blackburn, 1980, Effect of neurotensin on gastric function in man, Lancet, 1, 987, 10.1016/S0140-6736(80)91434-8 Nagai, 1976, Hyperglycemia and hyperglucagonemia following neurotensin administration, Life Sci, 19, 273, 10.1016/0024-3205(76)90400-8 Carraway, 1976, Hyperglycemic effect of neurotensin, a hypothalamic peptide, Endocrinology, 99, 1452, 10.1210/endo-99-6-1452 Brown, 1976, Effects of neurotensin and substance-P on plasma insulin, glucagon and glucose levels, Endocrinology, 98, 819, 10.1210/endo-98-3-819 Ahlman, 1988, SMS-201-995 and provocative testing in the preparation of patients with carcinoid for surgery and hepatic artery embolization, Anesth Anal, 67, 1142, 10.1213/00000539-198812000-00003 Tulassay, 1988, Benefit of somatostatin in dumping syndrome, Surgery, 103, 130 Hopman, 1988, Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995, Ann Surg, 207, 155, 10.1097/00000658-198802000-00007 Kapoor, 1987, Use of a long-acting somatostatin analog (Sandostatin, SMS 201-995) in the treatment of refractory postgastrectomy hypoglycemia, Clin Res, 35, 507A Hopman, 1987, Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995, Gastroenterology, 92, 1440 Johnston, 1987, Somatostatin analogue SMS 201-995 in the dumping syndrome: effect on packed cell volume (PCV), blood glucose (BG) and plasma GI peptides, Gut, 26, A1396 Primrose, 1987, Somatostatin analogue SMS 201-995 is an effective treatment for the post-gastric surgery-dumping syndrome provoked by hypertonic glucose, Gastroenterology, 92, 1580 Bramley, 1988, The use of octreotide (SMS 201-995) in the treatment of intractable dumping after vagotomy or gastrectomy, Gastroenterology, 94, A360 Kraenzlin, 1985, Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases, Gastroenterology, 88, 185, 10.1016/S0016-5085(85)80153-0 Garcia-Luna, 1988, Size changes of a growth hormone- and prolactin-producing adenoma during and after somatostatin treatment, Horm Res, 29, 109, 10.1159/000180982 Ducasse, 1987, Shrinking of a growth hormone-producing pituitary tumor by continuous subcutaneous infusion of the somatostatin analog SMS 201-995, J Clin Endocrinol Metab, 65, 1042, 10.1210/jcem-65-5-1042 De Quijada, 1983, Inhibition of growth of a prolactin-secreting pituitary tumor in rats by analogs of luteinizing hormone-release hormone and somatostatin, Proc Nat Acad Sci USA, 80, 3485, 10.1073/pnas.80.11.3485 Reubi, 1985, A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth, Acta Endocrinol, 109, 108, 10.1530/acta.0.1090108 Lamberts, 1986, Studies on the mechanism of action of the inhibitory effect of the somatostatin analog SMS 201-995 on the growth of the prolactin/adrenocorticotropin-secreting pituitary tumor 7315a, Endocrinology, 118, 2188, 10.1210/endo-118-6-2188 Seytano-Han, 1987, Direct inhibitory effects of somatostatin (analogs) on the growth of human breast cancer cells, Cancer Res, 47, 1566 Scambia, 1988, Antiproliferative effects of somatostatin and the somatostatin analog SMS 201-995 on three human breast cancer cell lines, J Cancer Res Clin Oncol, 114, 306, 10.1007/BF00405839 Redding, 1984, Inhibition of growth of pancreatic cancers in animal models by analogs of hypothalamic hormones, Proc Nat Acad Sci USA, 81, 248, 10.1073/pnas.81.1.248 Cai, 1986, Synthesis and biologic activity of highly potent octapeptide analogs of somatostatin, Proc Nat Acad Sci USA, 83, 1896, 10.1073/pnas.83.6.1896 McCumbee, 1980, Hormone responsiveness of a transplantable rat chondrosarcoma. II. Evidence for in vivo hormone dependence, Endocrinology, 106, 1930, 10.1210/endo-106-6-1930 Rose, 1982, Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea, Cancer Res, 42, 35 Emerman, 1985, Elevated growth hormone levels in sera from breast cancer patients, Horm Metab Res, 17, 421, 10.1055/s-2007-1013563 Minuto, 1986, Evidence for an increased somatomedin-C and insulin-like growth factor I content in primary human lung tumors, Cancer Res, 46, 985 Morel, 1985, Ultrastructural autoradioimmunologic localization of somatostatin-28 in the rat pituitary gland, Endocrinology, 116, 1615, 10.1210/endo-116-4-1615 Tragl, 1978, Effect of in vivo administration of somatostatin on cell-free protein synthesis of pituitary and of adrenal ribosomes, Metabolism, 27, 1887, 10.1016/0026-0495(78)90080-X Mascardo, 1982, Somatostatin inhibits rapid centrosomal separation and cell proliferation induced by epidermal growth factor, Endocrinology, 111, 1294, 10.1210/endo-111-4-1394 Buhrow, 1983, Characteristics of the interaction of the 5′-p-fluorosulfonylbenzoyl adenosine with the epidermal growth factor receptor/protein kinase in A431 cell membranes, J Biol Chem, 258, 7824, 10.1016/S0021-9258(18)32253-1 Hierowski, 1985, Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer M1A PaCa-2 cell line, FEBS Lett., 179, 252, 10.1016/0014-5793(85)80529-9 Sainsbury, 1985, Epidermal growth factor receptors and oestrogen receptors in human breast cancer, Lancet, 1, 364, 10.1016/S0140-6736(85)91385-6 Neal, 1985, Epidermal growth factor receptors in human bladder cancer: comparison of invasive and superficial tumours, Lancet, 1, 366, 10.1016/S0140-6736(85)91386-8 Kelly, 1983, Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor, Cell, 35, 603, 10.1016/0092-8674(83)90092-2 Klein, 1983, Specific chromosomal translocations and the genesis of B-cell-derived tumors of mice and men, Cell, 32, 311, 10.1016/0092-8674(83)90449-X Little, 1983, Amplification and expression of the c-myc oncogene in human lung cancer cell lines, Nature, 306, 194, 10.1038/306194a0 Downward, 1984, Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences, Nature, 307, 521, 10.1038/307521a0 Phillips, 1976, Tumor angiogenesis factor (TAF) in human and animal tumors, Int J Cancer, 17, 549, 10.1002/ijc.2910170502 Folkman, 1976, Relation of vascular proliferation to tumor growth, Int Rev Exp Path, 16, 207 Weidner, 1991, Tumor angiogenesis and metastasiscorrelation in invasive breast carcinoma, New Engl J Med, 324, 1, 10.1056/NEJM199101033240101 Woltering, 1991, Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane, J Surg Res, 50, 245, 10.1016/0022-4804(91)90186-P Dueno, 1987, Effect of somatostatin analog on water and electrolyte transport and transit time in human small bowel, Dig Dis Sci, 32, 1092, 10.1007/BF01300194 Ladefoged, 1989, Effect of a long-acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome, Gut, 30, 949, 10.1136/gut.30.7.943 Schiller, 1982, Studies of the mechanism of the antidiarrheal effect of codeine, J Clin Invest, 70, 999, 10.1172/JCI110711 Krejs, 1980, Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes, Gastroenterology, 78, 26, 10.1016/0016-5085(80)90188-2 Nubiola-Calonge, 1987, Blind evaluation of the effect of octreotide (SMS 201-995), a somatostatin analogue, on small-bowel fistula output, Lancet, 2, 672, 10.1016/S0140-6736(87)92452-4 Nubiola, 1989, Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analog SMS 201-995, Ann Surg, 210, 56, 10.1097/00000658-198907000-00009 Sitges-Serra, 1982, Management of post-operative enterocutaneous fistulas: The roles of parenteral nutrition and surgery, Br J Surg, 69, 147, 10.1002/bjs.1800690310 Farber, 1986, Stress, symmetry and psoriasis: possible role of neuropeptides, J Am Acad Derm, 14, 305, 10.1016/S0190-9622(86)70034-0 Farber, 1974, The natural history of psoriasis in 5600 patients, Dermatologica, 148, 1, 10.1159/000251595 Weber, 1982, Treatment of psoriasis with somatostatin, Arch Dermatol Res, 272, 31, 10.1007/BF00510390 Williams, 1986, Postprandial effects of SMS 201-995 on gut hormones and glucose tolerance, Scand J Gastroenterol, 199, 73, 10.3109/00365528609087434 Camisa, 1990, Treatment of psoriasis with chronic subcutaneous administration of somatostatin analog 201-995 (San-dostatin): I. An open-label pilot study, Clev Clin J Med, 57, 71, 10.3949/ccjm.57.1.71 Clemmons, 1984, Multiple hormones stimulate the production of somatomedin by cultured human fibroblasts, J Clin Endocrinol Metab, 58, 850, 10.1210/jcem-58-5-850 Saiag, 1985, Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro, Science, 230, 666, 10.1126/science.2413549 Nannex, 1986, Altered [I-125] epidermal growth factor binding and receptor distribution in psoriasis, J Invest Derm, 86, 260, 10.1111/1523-1747.ep12285389 Ghirlanda, 1983, Epidermal growth factor, somatostatin and psoriasis, Lancet, 65, 10.1016/S0140-6736(83)91594-5 Nilsson, 1985, Stimulation of connective tissue growth by substance-P and substance-K, Nature, 315, 61, 10.1038/315061a0 Hartung, 1984, Binding of substance-P to macrophages: stimulation of proinflammatory and immunomodulating compounds, Neurosci Letts, 18, S101 Levine, 1984, Intraneuronal substance-P contributes to the severity of experimental arthritis, Science, 226, 547, 10.1126/science.6208609 Gazelius, 1984, Evidence that substance-P is a mediator of antidromic vasodilatation using somatostatin as a release inhibitor, Acta Phys Scand, 113, 155, 10.1111/j.1748-1716.1981.tb06876.x Vinik, 1990, Plasma substance-P in neuroendocrine tumors and idiopathic flushing: the value of pentagastrin stimulation tests and the effects of somatostatin analog, J Clin Endocrinol Metab, 70, 1702, 10.1210/jcem-70-6-1702 Balks, 1989, Effect of a long-acting somatostatin analog (octreotide) on circulating tachykinins and the pentagastrin induced carcinoid flush, Eur J Clin Pharm, 36, 133, 10.1007/BF00609184 Stanisz, 1987, In vitro studies of immunoregulation by substance-P and somatostatin, Ann NY Acad Sci, 496, 217, 10.1111/j.1749-6632.1987.tb35769.x Matucci-Cerinic, 1988, Somatostatin treatment of psoriatic arthritis, Int J Derm, 27, 56, 10.1111/j.1365-4362.1988.tb02341.x Hokfelt, 1976, Immunohistochemical evidence for separate populations of somatostatin-containing and substance-P-containing primary afferent neurons in the rat, Neuroscience, 1, 131, 10.1016/0306-4522(76)90008-7 Massari, 1983, Distribution and origin of bombesin, substance-P, and somatostatin in cat spinal cord, Peptides, 4, 673, 10.1016/0196-9781(83)90017-7 Tisco, 1990, Differential release of substance-P and somatostatin in rat spinal cord in response to noxious cold and heat: effect of dynorphin A (1–17), J Pharm Exp Ther, 252, 539 Ohkubo, 1990, Roles of substance-P and somatostatin on transmission of nociceptive information induced by formalin in the spinal cord, J Pharm Exp Ther, 252, 1261 Randic, 1978, Depressant actions of methionine enkephalin and somatostatin in cat dorsal horn neurones activated by noxious stimuli, Brain Res, 152, 196, 10.1016/0006-8993(78)90148-8 Renaud, 1975, Depressive actions of TRH, LH-RH, and somatostatin on the activity of central neurones, Nature, 255, 233, 10.1038/255233a0 Meynadier, 1985, Intrathecal somatostatin in terminally ill patients: a report of two cases, Pain, 23, 9, 10.1016/0304-3959(85)90224-6 Chrubasik, 1985, The effect of epidural somatostatin on post-operative pain, Anesth Analgesia, 64, 1085, 10.1213/00000539-198511000-00009 Gaumann, 1989, Intrathecal somatostatin in cat and mouse studies on pain, motor behavior and histopathology, Anesth Analgesia, 68, 623, 10.1213/00000539-198905000-00015 Williams, 1987, Analgesic effect of somatostatin analogue (octreotide) in headache associated with pituitary tumours, Br Med J, 295, 247, 10.1136/bmj.295.6592.247 Panconesi, 1985, Powerful vasospastic activity in man of an analogue of somatostatin (SMS 201-995), a potential symptomatic agent in cluster headache, Cephalalgia, 5, 36, 10.1177/03331024850050S306 Hoeldtke, 1986, Treatment of autonomic neuropathy with a somatostatin analog, SMS-201-995, Lancet, 602, 10.1016/S0140-6736(86)92428-1 Hoeldtke, 1989, Treatment of orthostatic hypotension with octreotide, J Clin Endocrinol Metab, 68, 1051, 10.1210/jcem-68-6-1051 Cacabelos, 1988, Influence of somatostatin and growth hormone-releasing factor on behavior: clinical and therapeutic implications in neuropsychiatric disorders, Horm Res, 29, 129, 10.1159/000180988 Vecsei, 1984, Comparative studies with somatostatin and cysteamine in different behavior tests on rats, Pharm Biochem Behavior, 21, 833, 10.1016/S0091-3057(84)80061-1 Vecsei, 1989, Comparative studies of somatostatin-14 and some of its fragments on avoidance behavior, open field and barrel rotation phenomena in rats, Peptides, 10, 1153, 10.1016/0196-9781(89)90007-7 Vecsei, 1990, Effects of somatostatin-28 and some of its fragments and analogs on open field behavior, barrel rotation and shuttle box learning in rats, Psychoneuroendo, 15, 139, 10.1016/0306-4530(90)90022-2 LeBlanc, 1988, Neurobehavioral effects of intrathecal somatostatinergic treatment in subhuman primates, Neurology, 38, 1887, 10.1212/WNL.38.12.1887 Gerner, 1982, Altered neuropeptide concentration in cerebrospinal fluid of psychiatric patients, Brain Res, 238, 298, 10.1016/0006-8993(82)90801-0 Danguir, 1988, Food intake in rats is increased by intracerebroventricular infusion of the somatostatin analog SMS 201-995 and is decreased by somatostatin antiserum, Peptides, 9, 211, 10.1016/0196-9781(88)90030-7 Aponte, 1984, Effects of somatostatin on food intake in rats, Life Sci, 35, 741, 10.1016/0024-3205(84)90342-4 Shibasuki, 1988, Involvement of corticotropin-releasing factor in restraint stress-induced anorexia and reversion of the anorexia by somatostatin in the rat, Life Sci, 3, 1103, 10.1016/0024-3205(88)90468-7 Grabow, 1984, Electroencephalographic and behavioral assessment of intracerebroventricular somatostatin and a substance-P analog, Brain Res, 489, 223, 10.1016/0006-8993(89)90854-8 Rabinow, 1987, Somatostatin and GHRH: mood and behavior regulation, Adv Biochem Psychopharm, 43, 137 Rezek, 1976, Continuous administration of somatostatin (SRIF): Effect on sleep and motor behavior, Pharm Biochem Behavior, 5, 73, 10.1016/0091-3057(76)90290-2 Resek, 1977, Behavioral and motor excitation and inhibition by the administration of small and large doses of somatostatin into the amygdala, Neuropharm, 16, 157, 10.1016/0028-3908(77)90090-9 Danguir, 1989, Reversal of desipramine-induced suppression of paradoxical sleep by a long-acting somatostatin analog (octreotide) in rats, Neurosci Letts, 98, 154, 10.1016/0304-3940(89)90502-8 Vecsei, 1983, Intracerebroventricular somatostatin attenuates electroconvulsive shock-induced amnesia in rats, Peptides, 4, 293, 10.1016/0196-9781(83)90135-3 Cacabelos, 1986, Neuroendocrine correlates in senile dementia of the Alzheimer's type, Progr Clin Neurosci, 2, 231 Quirion, 1986, Neurotransmitter and reception deficits in senile dementia of the Alzheimer's type, Can J Neurosci, 13, 503 Gauthier, 1986, Transmitter replacement therapy in Alzheimer's using intracerebroventricular infusion of receptor agonists, Can J Neurol Sci, 13, 394, 10.1017/S0317167100036969 Armstrong, 1989, Substance-P and somatostatin coexist within neuritic plaques: implications for the pathogenesis of Alzheimer's disease, Neurosci, 31, 663, 10.1016/0306-4522(89)90431-4 Roberts, 1985, Localization of neuronal tangles in somatostatin neurones in Alzheimer's disease, Nature, 314, 92, 10.1038/314092a0 Tamminga, 1985, Alzheimer's disease: somatostatin loss in an area of maximal fluorodeoxy-glucose reduction, Neurology, 35, 183 Cutler, 1985, L-363, 586, a somatostatin analog. An assortment of memory function in Alzheimer's disease, Neurology, 35, 265 Nemoeroff, 1983, Regional brain concentration of neuropeptides in Huntington's chorea and schizophrenia, Science, 221, 972, 10.1126/science.6136092 Epelbaum, 1988, Somatostatin concentration and binding sites in human frontal cortex are differentially affected in Parkinson's disease associated dementia and in progressive supranuclear palsy, J Neurol, 87, 167 Masson, 1990, Somatostatin-like immunoreactivity in the cerebrospinal fluid of aged patients with Parkinson's disease, J Am Geriatrics Soc, 38, 19, 10.1111/j.1532-5415.1990.tb01591.x Sorenson, 1980, Low somatostatin content of cerebrospinal fluid in multiple sclerosis: an indicator of disease activity?, Acta Neurol Scand, 61, 186, 10.1111/j.1600-0404.1980.tb01481.x Rosler, 1990, Cerebrospinal fluid levels of immunoreactive substance-P and somatostatin in patients with multiple sclerosis and inflammatory CNS disease, Peptides, 11, 181, 10.1016/0196-9781(90)90129-S